Energy Specific Far Infrared Radiation Treatment for Erectile Dysfunction
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00573209|
Recruitment Status : Unknown
Verified August 2009 by GAAD Medical Research Institute Inc..
Recruitment status was: Active, not recruiting
First Posted : December 14, 2007
Last Update Posted : August 17, 2009
|Condition or disease||Intervention/treatment||Phase|
|Erectile Dysfunction||Radiation: Far Infrared Radiation||Phase 1|
Erectile dysfunction is characterized by the regular or repeated inability to obtain or maintain an erection. Erection depends on a complex interaction of psychological, neural, vascular and endocrine factors.
We are proposing a non-drug and a non-invasive radiation treatment for the enhancement of erection.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||3 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Erectile Dysfunction.|
|Study Start Date :||August 2007|
|Actual Primary Completion Date :||February 2009|
|Estimated Study Completion Date :||May 2009|
Radiation: Far Infrared Radiation
Far Infrared Radiation (5μm to 20μm wavelength) for 30 to 40 minutes each session.
- The primary end point is to determine the therapeutic effects of far infrared radiation on erectile dysfunction. [ Time Frame: 1 year ]
- The effect of far infrared radiation on other male conditions like prostate cancer [ Time Frame: 1 year ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00573209
|The Centre for Incurable Diseases|
|Mississauga, Ontario, Canada, L5R 3G9|
|Study Director:||Ken Nedd, M.D.||GAAD Medical Research Institute Inc.|
|Study Chair:||Kwasi Donyina, Ph.D.||GAAD Medical Research Institute Inc.|